Initiating dopaminergic treatment in Parkinson's disease
Authors:
- 1 September 2014
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 384 (9949) , 1164-1166
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's diseaseMovement Disorders, 2013
- Impulse Control Disorders in Parkinson DiseaseArchives of Neurology, 2010
- Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson DiseaseArchives of Neurology, 2009
- Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PDNeurology, 2008
- Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET studyMovement Disorders, 2006
- “Levodopa phobia”: A new iatrogenic cause of disability in Parkinson diseaseNeurology, 2005
- A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or LevodopaNew England Journal of Medicine, 2000
- Early Treatment of Parkinson??s Disease with Cabergoline Delays the Onset of Motor ComplicationsDrugs, 1998
- The oxidant stress hypothesis in Parkinson's disease: Evidence supporting itAnnals of Neurology, 1992
- Young onset Parkinson's diseaseMovement Disorders, 1987